Please ensure Javascript is enabled for purposes of website accessibility

Is Aurora Cannabis Stock a Buy?

By Joe Tenebruso – May 19, 2020 at 1:27PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Ladenburg Thalmann's analyst says yes.

Even after soaring by more than 125% over the past week, shares of Aurora Cannabis (ACB -3.12%) still have plenty of upside.

So says investment bank Ladenburg Thalmann, which reiterated its buy rating on Aurora's stock on Monday. Even after cutting his price target in half, analyst Glenn Mattson says Aurora's shares are still worth significantly more than the price at which they're currently trading. Mattson thinks the marijuana industry leader's stock is worth at least $18, which is about 24% more than shares were fetching at 1:15 p.m. EDT Tuesday.

A miniature gold bull on top of a keyboard button labeled buy.

Aurora Cannabis's stock is still a buy, according to analysts at Ladenburg Thalmann. Image source: Getty Images.

Mattson commended Aurora for its better-than-expected sales growth in its fiscal third quarter, which ended March 31. The cannabis producer's total net revenue surged 35% sequentially to $75.5 million, driven in part by a 24% jump in recreational consumer cannabis sales to $41.5 million. Those figures were well above Mattson's projections for total net revenue and consumer cannabis sales of $67.6 million and $36.6 million, respectively.

Mattson also applauded Aurora's newfound financial discipline. The previously free-spending company has instituted a series of cost-reduction initiatives to slow its cash burn and shore up its balance sheet. In light of these efforts, he believes Aurora will soon begin to generate positive cash flow from its home market of Canada.

"We think ACB can become a solid cash flow generator simply from the Canadian operations and, with a strong market position in Canada, the company can create significant value from here based on this one market," Mattson said.

Looking ahead, he expects Aurora to eventually build a significant presence in the U.S., where marijuana sales are forecast to be as much as 12 times higher than the Canadian cannabis market by 2024. 

"We do think that it will look to expand into the U.S. but not until federal legality is more clear," Mattson said.

Joe Tenebruso has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Aurora Cannabis Inc. Stock Quote
Aurora Cannabis Inc.
ACB
$1.24 (-3.12%) $0.04

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
342%
 
S&P 500 Returns
110%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 10/06/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.